ArticleJournal of gastrointestinal oncology2022

Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review.

Ming Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.